文献速递鼻科

组织活检部位对慢性鼻窦炎伴鼻息肉临床相关性的前瞻性分析

A prospective analysis evaluating tissue biopsy location and its clinical relevance in chronic rhinosinusitis with nasal polyps.
PubMed 文献 · Int Forum Allergy Rhinol · 2017-09-01

该前瞻性研究纳入116例慢性鼻窦炎伴鼻息肉(CRSwNP)患者,采用ELISA法检测钩突组织(UT)和鼻息肉(NP)匀浆中的嗜酸性粒细胞阳离子蛋白(ECP)水平,分析其与影像学严重度、共病及术后息肉复发的关系。结果显示UT组织嗜酸性粒细胞增多与Lund-Mackay评分、哮喘和AERD显著相关,且仅UT组织嗜酸性粒细胞增多可预测息肉复发风险(HR=2.84,p=0.025)。

要点

  • UT组织ECP与Lund-Mackay评分相关性(r=0.46)强于NP组织(r=0.26)。
  • UT组织ECP在哮喘(p<0.01)和AERD(p<0.05)患者中显著升高,NP组织无此关联。
  • 仅UT组织嗜酸性粒细胞增多与息肉复发风险显著相关(HR=2.84,p=0.025)。

核心结论

  • UT组织嗜酸性粒细胞增多是比NP组织更一致的生物标志物,可反映基线影像学严重度、哮喘和AERD共病及息肉复发风险。

研究设计与样本

  • 前瞻性分析116例CRSwNP患者,采用ELISA检测UT和NP组织匀浆中ECP水平,并从电子健康记录获取临床病史、影像学严重度和复发时间。

主要发现

  • Lund-Mackay评分与UT和NP组织ECP均显著相关(r=0.46和0.26,p<0.05)。
  • UT组织ECP在哮喘(p<0.01)和AERD(p<0.05)患者中显著更高,NP组织ECP无此差异。
  • UT组织嗜酸性粒细胞增多者息肉复发风险显著更高(HR=2.84,p=0.025),NP组织嗜酸性粒细胞增多未预测复发。

关键数值与推荐

  • 嗜酸性粒细胞增多定义为组织ECP水平升高,检测方法为ELISA。
  • 复发风险分析采用Cox回归和Kaplan-Meier法,删失时间为4年或无复发诊断的末次随访。

临床怎么用

  • 临床评估CRSwNP患者时,优先检测UT组织嗜酸性粒细胞水平以预测疾病严重度和复发风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) has a high propensity for recurrence. Studies suggest that eosinophilia influences disease severity and surgical outcomes, but the selection of sinonasal site for measuring eosinophilia has not been examined. The aim of this study was to investigate how region-specific tissue eosinophilia affects radiographic severity, comorbidity prevalence, and polyp recurrence risk following sinus surgery. METHODS: Eosinophil cationic protein (ECP) levels in uncinate tissue (UT) and nasal polyp (NP) homogenates from 116 CRSwNP patients were measured using enzyme-linked immunosorbent assay (ELISA). Clinical history, radiographic severity, and time to polyp recurrence were obtained from electronic health records. The correlations between baseline Lund-Mackay scores and comorbidities were compared between UT and NP ECP levels. Cox regression and Kaplan-Meier analysis were then performed to assess whether UT or NP ECP better predicted recurrence. Censoring occurred at 4 years or at last follow-up if there was no endoscopic diagnosis of recurrent polyps. RESULTS: Lund-Mackay scores were significantly correlated with UT and NP ECP (r = 0.46 and 0.26 respectively, p < 0.05). UT but not NP ECP was significantly higher in patients with asthma (p < 0.01) and aspirin-exacerbated respiratory disease (AERD) (p < 0.05). Polyp recurrence risk was only significantly higher for patients with eosinophilic UT tissue (hazard ratio [HR] = 2.84, p = 0.025). When measured in NP, eosinophilia did not predict recurrence. CONCLUSION: Although ECP in NP was higher than in UT tissue, eosinophilia in UT tissue was a more clinically coherent biomarker of baseline radiographic severity, comorbid asthma and AERD, and prospective polyp recurrence risk than NP eosinophilia.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Weibman AR, Huang JH, Stevens WW, et al. A prospective analysis evaluating tissue biopsy location and its clinical relevance in chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2017. PMID: 28863237. doi:10.1002/alr.22005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。